---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-25-018108"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:44:39.525026+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tonix Pharma expands share repurchase program by $25M to $35M total authorized

## Summary
- Board approved an additional $25.0 million for share repurchases, raising total authorized to $35.0 million.
- Repurchases may occur from time to time in open-market or private transactions depending on conditions.
- The original $10 million authorization was increased; no expiration date or commitment to repurchase any specific number of shares.

## SEC filing metadata
- accession: 0001999371-25-018108
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000199937125018108/0001999371-25-018108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000199937125018108/tnxp-8k_111825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-25-018108
- JSON: https://secwatch.observer/filing/0001999371-25-018108.json
- Plain text: https://secwatch.observer/filing/0001999371-25-018108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.